Support Person Intervention to Promote a Smoking Helpline

Status Completed

Clinical Trial Summary

This study is designed to examine if a telephone-based intervention delivered to a support person (i.e., friend, spouse of a smoker) increases the smoker's use of the Minnesota helpline. In addition, the study will examine if the rate of smoker calls to the helpline is greater if the support person receives 3 intervention calls, 1 intervention call, or no calls (written materials only, control condition).

Clinical Trial Description

We will conduct a randomized clinical trial within the ongoing service of the QUITPLAN® Helpline. Our primary aim is to examine the efficacy of two levels of telephone counseling for support persons (1 or 3 sessions) compared with a control condition on the proportion of smokers who call the Helpline over the 7 month follow-up period. We hypothesize a dose response relationship between number of telephone sessions provided to the support persons and smoker calls to the Helpline. Additional aims are to examine smoker quit attempts and cessation, and cost-effectiveness of the interventions.

Nonsmoking adult support persons (N=1020) residing in Minnesota will be enrolled and randomly assigned to one of three study conditions: (1) control condition -written self-help materials, (2) written materials plus one telephone session, or (3) written materials plus three telephone sessions. Outcome assessments will be completed by support persons and smokers at post-treatment (week 4) and at 7 month follow-up.

This design will allow for evaluation of whether results from our previous trial (Patten et al., in press, AJPM) can be replicated when the intervention is implemented within a "real-world" setting. That is all support person intervention calls will be delivered by the Helpline. Moreover, we will examine the potential efficacy and cost-effectiveness of a streamlined version of the intervention (i.e., 1 call). Furthermore, the proposed study will provide new data on quit attempts and cessation among the smokers. Ultimately, positive findings from this line of research could serve as the basis for expanding the range of helpline services to nonsmokers. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Tobacco Cessation

Clinical Trial Details

NCT number	NCT01331226
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	N/A
Start date	July 2011
Completion date	April 2015

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05415371` - Persistent Poverty Counties Pregnant Women With Medicaid	N/A
Not yet recruiting	`NCT04501016` - A Stepped Care Approach to Treating Tobacco Use in Rural Veterans	Phase 2/Phase 3
Completed	`NCT01651611` - Intervention Study to Increase Smoking Cessation Rates Among Public Housing Residents	N/A
Completed	`NCT01570595` - Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV	Phase 1/Phase 2
Completed	`NCT01099384` - Tobacco Cessation Treatment for Alaska Native Youth	Phase 1
Completed	`NCT01164306` - The Impact of a Tobacco Control Intervention in African-American Families	N/A
Recruiting	`NCT04865276` - Adaptation and Evaluation of a Culturally and Gender Relevant Tobacco Cessation Among Women in Brazil: An Integrated mHealth Approach	N/A
Recruiting	`NCT02103868` - Medium Vs Low Intensity Intervention in Tobacco Cessation and Control in Zari Workers	N/A
Completed	`NCT00836199` - NicVAX/Placebo as an Aid for Smoking Cessation	Phase 3
Recruiting	`NCT05552534` - Impact of an Intervention of Screening, Treatment Initiation and Referral to PROmote Smoking CEssation in Emergency Department Patients	N/A
Completed	`NCT01482923` - Tobacco Assessment and Intervention With Low-Income Persons Living With HIV-AIDS (PLWHA) in Community-Based AIDS Service Organizations
Completed	`NCT05764343` - The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases	N/A
Completed	`NCT01312480` - Adolescent Smoking Cessation in Pediatric Primary Care	N/A
Completed	`NCT03377738` - Effectiveness of the Spirometry Test as a Motivational Tool for Quitting Tobacco in Primary Care	N/A
Completed	`NCT03096145` - Support Person Intervention to Promote a Smoking Helpline Among Under Resourced Smokers	N/A
Completed	`NCT05095779` - Incentives for Smoking Cessation in Persistent Poverty Counties	N/A
Completed	`NCT03062709` - A Study of Tobacco Smoke and Children With Respiratory Illnesses	N/A
Completed	`NCT00750503` - Workplace Tobacco Cessation And Oral Cancer Screening Study	Phase 3
Withdrawn	`NCT04340102` - Development of a Scalable Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness	N/A
Completed	`NCT04198688` - Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Support Person Intervention to Promote a Smoking Helpline — ClearWay #4

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms